These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32854257)

  • 1. A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery.
    Gasparello J; Papi C; Allegretti M; Giordani E; Carboni F; Zazza S; Pescarmona E; Romania P; Giacomini P; Scapoli C; Gambari R; Finotti A
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs miR-584-5p and miR-425-3p Are Up-Regulated in Plasma of Colorectal Cancer (CRC) Patients: Targeting with Inhibitor Peptide Nucleic Acids Is Associated with Induction of Apoptosis in Colon Cancer Cell Lines.
    Gasparello J; Papi C; Zurlo M; Gambari L; Manicardi A; Rozzi A; Ferrarini M; Corradini R; Gambari R; Finotti A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X; Shi K; Wang Y; Song M; Zhou W; Tu H; Lin Z
    Oncotarget; 2015 Nov; 6(35):37544-56. PubMed ID: 26462034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis.
    Rapado-González Ó; Majem B; Álvarez-Castro A; Díaz-Peña R; Abalo A; Suárez-Cabrera L; Gil-Moreno A; Santamaría A; López-López R; Muinelo-Romay L; Suarez-Cunqueiro MM
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31757017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of A 6-Mirna Signature in Serum from Colorectal Cancer Screening Participants as Non-Invasive Biomarkers for Advanced Adenoma and Colorectal Cancer Detection.
    Marcuello M; Duran-Sanchon S; Moreno L; Lozano JJ; Bujanda L; Castells A; Gironella M
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
    Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
    Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
    Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
    BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
    Pehserl AM; Ress AL; Stanzer S; Resel M; Karbiener M; Stadelmeyer E; Stiegelbauer V; Gerger A; Mayr C; Scheideler M; Hutterer GC; Bauernhofer T; Kiesslich T; Pichler M
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating plasma microRNAs in colorectal neoplasia: A pilot study in assessing response to therapy.
    O'Brien SJ; Netz U; Hallion J; Bishop C; Stephen V; Burton J; Paas M; Feagins K; Pan J; Rai SN; Galandiuk S
    Transl Oncol; 2021 Jan; 14(1):100962. PubMed ID: 33285367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer.
    Pan C; Yan X; Li H; Huang L; Yin M; Yang Y; Gao R; Hong L; Ma Y; Shi C; Qin H; Zhang P
    Oncotarget; 2017 Sep; 8(40):68317-68328. PubMed ID: 28978119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.